Titre : Tomodensitométrie multidétecteurs

Tomodensitométrie multidétecteurs : Questions médicales fréquentes

Termes MeSH sélectionnés :

Patents as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tomodensitométrie multidétecteurs : Questions médicales les plus fréquentes", "headline": "Tomodensitométrie multidétecteurs : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tomodensitométrie multidétecteurs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-25", "dateModified": "2025-02-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tomodensitométrie multidétecteurs" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tomodensitométrie hélicoïdale", "url": "https://questionsmedicales.fr/mesh/D036542", "about": { "@type": "MedicalCondition", "name": "Tomodensitométrie hélicoïdale", "code": { "@type": "MedicalCode", "code": "D036542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E01.370.350.825.810.810.800" } } }, "about": { "@type": "MedicalCondition", "name": "Tomodensitométrie multidétecteurs", "alternateName": "Multidetector Computed Tomography", "code": { "@type": "MedicalCode", "code": "D061330", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sanjeev Kumar", "url": "https://questionsmedicales.fr/author/Sanjeev%20Kumar", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Arun Sharma", "url": "https://questionsmedicales.fr/author/Arun%20Sharma", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Mumun Sinha", "url": "https://questionsmedicales.fr/author/Mumun%20Sinha", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Niraj Nirmal Pandey", "url": "https://questionsmedicales.fr/author/Niraj%20Nirmal%20Pandey", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Niraj N Pandey", "url": "https://questionsmedicales.fr/author/Niraj%20N%20Pandey", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Recent advances in the development of STING inhibitors: an updated patent review.", "datePublished": "2022-11-09", "url": "https://questionsmedicales.fr/article/36332188", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13543776.2022.2144220" } }, { "@type": "ScholarlyArticle", "name": "Current status and patent prospective of lipid nanoparticle for mRNA delivery.", "datePublished": "2023-03-28", "url": "https://questionsmedicales.fr/article/36958374", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13543776.2023.2195541" } }, { "@type": "ScholarlyArticle", "name": "SUMO-specific protease 1 inhibitors-A literature and patent overview.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/36631420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13543776.2022.2165910" } }, { "@type": "ScholarlyArticle", "name": "An updated patent review of IDO1 inhibitors for cancer (2018-2022).", "datePublished": "2022-12-06", "url": "https://questionsmedicales.fr/article/36420761", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13543776.2022.2151894" } }, { "@type": "ScholarlyArticle", "name": "The impact of patent infringement litigation decisions on firms' innovation performance in China.", "datePublished": "2024-10-09", "url": "https://questionsmedicales.fr/article/39384940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-74924-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Diagnostic", "item": "https://questionsmedicales.fr/mesh/D003933" }, { "@type": "ListItem", "position": 3, "name": "Techniques et procédures diagnostiques", "item": "https://questionsmedicales.fr/mesh/D019937" }, { "@type": "ListItem", "position": 4, "name": "Imagerie diagnostique", "item": "https://questionsmedicales.fr/mesh/D003952" }, { "@type": "ListItem", "position": 5, "name": "Tomographie", "item": "https://questionsmedicales.fr/mesh/D014054" }, { "@type": "ListItem", "position": 6, "name": "Tomographie à rayons X", "item": "https://questionsmedicales.fr/mesh/D014056" }, { "@type": "ListItem", "position": 7, "name": "Tomodensitométrie", "item": "https://questionsmedicales.fr/mesh/D014057" }, { "@type": "ListItem", "position": 8, "name": "Tomodensitométrie hélicoïdale", "item": "https://questionsmedicales.fr/mesh/D036542" }, { "@type": "ListItem", "position": 9, "name": "Tomodensitométrie multidétecteurs", "item": "https://questionsmedicales.fr/mesh/D061330" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tomodensitométrie multidétecteurs - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tomodensitométrie multidétecteurs", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tomodensitométrie multidétecteurs", "description": "Quels sont les principaux usages de la tomodensitométrie multidétecteurs ?\nComment la TDM multidétecteurs aide-t-elle au diagnostic du cancer ?\nLa TDM peut-elle détecter des maladies cardiovasculaires ?\nQuels types de pathologies peuvent être évalués par TDM ?\nLa TDM multidétecteurs est-elle utile en cas de traumatisme ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tomodensitométrie multidétecteurs", "description": "Quels symptômes peuvent nécessiter une TDM ?\nLa TDM peut-elle aider à évaluer des symptômes respiratoires ?\nQuels signes neurologiques justifient une TDM ?\nLa TDM est-elle utile pour des douleurs thoraciques ?\nQuels symptômes digestifs peuvent nécessiter une TDM ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tomodensitométrie multidétecteurs", "description": "La TDM peut-elle être utilisée en dépistage préventif ?\nQuels facteurs de risque justifient une TDM préventive ?\nLa TDM peut-elle aider à prévenir des complications ?\nComment la TDM contribue-t-elle à la prévention des maladies ?\nLa TDM est-elle recommandée pour les personnes à risque ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tomodensitométrie multidétecteurs", "description": "La TDM est-elle utilisée pour guider des traitements ?\nPeut-on utiliser la TDM pour surveiller l'évolution d'une maladie ?\nLa TDM peut-elle aider à planifier une chirurgie ?\nQuels traitements peuvent être guidés par TDM ?\nLa TDM est-elle utilisée pour évaluer l'efficacité d'un traitement ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tomodensitométrie multidétecteurs", "description": "Quelles sont les complications possibles de la TDM ?\nLa TDM peut-elle causer des effets secondaires ?\nComment minimiser les risques liés à la TDM ?\nLes patients peuvent-ils avoir des allergies au produit de contraste ?\nQuelles précautions prendre avant une TDM ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tomodensitométrie multidétecteurs", "description": "Quels sont les facteurs de risque pour des examens TDM fréquents ?\nLes enfants sont-ils plus à risque avec la TDM ?\nComment l'âge influence-t-il le risque lié à la TDM ?\nLes femmes enceintes doivent-elles éviter la TDM ?\nQuels comportements augmentent le risque de maladies nécessitant une TDM ?", "url": "https://questionsmedicales.fr/mesh/D061330?mesh_terms=Patents+as+Topic&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels sont les principaux usages de la tomodensitométrie multidétecteurs ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée pour diagnostiquer des maladies, évaluer des traumatismes et guider des interventions." } }, { "@type": "Question", "name": "Comment la TDM multidétecteurs aide-t-elle au diagnostic du cancer ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de visualiser les tumeurs, évaluer leur taille et détecter des métastases." } }, { "@type": "Question", "name": "La TDM peut-elle détecter des maladies cardiovasculaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est efficace pour visualiser les artères coronaires et détecter des anomalies." } }, { "@type": "Question", "name": "Quels types de pathologies peuvent être évalués par TDM ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elle évalue les pathologies pulmonaires, abdominales, neurologiques et osseuses." } }, { "@type": "Question", "name": "La TDM multidétecteurs est-elle utile en cas de traumatisme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet une évaluation rapide des blessures internes et des hémorragies." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter une TDM ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des maux de tête persistants ou des traumatismes peuvent l'exiger." } }, { "@type": "Question", "name": "La TDM peut-elle aider à évaluer des symptômes respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour diagnostiquer des infections pulmonaires ou des embolies." } }, { "@type": "Question", "name": "Quels signes neurologiques justifient une TDM ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes tels que des vertiges, des troubles de la vision ou des pertes de conscience." } }, { "@type": "Question", "name": "La TDM est-elle utile pour des douleurs thoraciques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à évaluer des causes comme l'embolie pulmonaire ou l'infarctus du myocarde." } }, { "@type": "Question", "name": "Quels symptômes digestifs peuvent nécessiter une TDM ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales aiguës, des vomissements ou des saignements gastro-intestinaux." } }, { "@type": "Question", "name": "La TDM peut-elle être utilisée en dépistage préventif ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est parfois utilisée pour le dépistage du cancer du poumon chez les fumeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque justifient une TDM préventive ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de cancer ou des expositions professionnelles à des agents cancérigènes." } }, { "@type": "Question", "name": "La TDM peut-elle aider à prévenir des complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de détecter précocement des anomalies pouvant mener à des complications." } }, { "@type": "Question", "name": "Comment la TDM contribue-t-elle à la prévention des maladies ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet une détection précoce des maladies, facilitant des interventions rapides." } }, { "@type": "Question", "name": "La TDM est-elle recommandée pour les personnes à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être recommandée pour les personnes à risque élevé de certaines pathologies." } }, { "@type": "Question", "name": "La TDM est-elle utilisée pour guider des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à guider des biopsies, des drainages ou des interventions chirurgicales." } }, { "@type": "Question", "name": "Peut-on utiliser la TDM pour surveiller l'évolution d'une maladie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de suivre la réponse au traitement et l'évolution des lésions." } }, { "@type": "Question", "name": "La TDM peut-elle aider à planifier une chirurgie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle fournit des images précises pour une meilleure planification chirurgicale." } }, { "@type": "Question", "name": "Quels traitements peuvent être guidés par TDM ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme la radiothérapie ou l'injection de médicaments ciblés." } }, { "@type": "Question", "name": "La TDM est-elle utilisée pour évaluer l'efficacité d'un traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de visualiser la réduction des tumeurs ou des lésions après traitement." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la TDM ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'exposition aux radiations et des réactions allergiques au contraste." } }, { "@type": "Question", "name": "La TDM peut-elle causer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires peuvent survenir, notamment des nausées ou des réactions cutanées." } }, { "@type": "Question", "name": "Comment minimiser les risques liés à la TDM ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "En limitant le nombre d'examens et en utilisant des techniques de réduction de dose." } }, { "@type": "Question", "name": "Les patients peuvent-ils avoir des allergies au produit de contraste ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des allergies au produit de contraste utilisé." } }, { "@type": "Question", "name": "Quelles précautions prendre avant une TDM ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Informer le médecin des allergies, des maladies rénales et des médicaments en cours." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour des examens TDM fréquents ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition antérieure aux radiations et des antécédents de cancer augmentent les risques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque avec la TDM ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux effets des radiations, nécessitant prudence." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque lié à la TDM ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir un risque accru de complications liées à la TDM." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter la TDM ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la TDM est généralement évitée pendant la grossesse en raison des risques pour le fœtus." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de maladies nécessitant une TDM ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'alcoolisme et une mauvaise alimentation augmentent les risques de maladies." } } ] } ] }

Sources (4427 au total)

Recent advances in the development of STING inhibitors: an updated patent review.

STING is at the center of the cGAS-STING signaling and acts as the hub of the innate immune system. Hyper-activation of STING has been observed in various severe autoimmune diseases, such as AGS, SLE,... Small-molecule STING inhibitors reported in patents (disclosed before May 2022 through the public database at https://worldwide.espacenet.com) were summarized in this review and the available structur... Compared with STING agonists, the development of STING inhibitors is still in its infancy and no candidates have entered clinical investigation stage. Fortunately, patent applications are appearing at...

Current status and patent prospective of lipid nanoparticle for mRNA delivery.

Messenger RNA-lipid nanoparticle (mRNA-LNP) delivery is currently a research hotspot in pharmaceutics. LNP has emerged in pharmaceutical industry as popular and effective vehicle for mRNA delivery. It... This article provides patent landscape and recent development for mRNA-LNP delivery by US-granted patent analysis. The US-granted patents from January 2003 to December 2022 were retrieved and analyzed... Globally, the present article was the first one which showed that mRNA-LNP delivery system demonstrated three therapeutic applications including vaccines, anticancer, and diseases associated with prot...

SUMO-specific protease 1 inhibitors-A literature and patent overview.

Cancer is currently one of the biggest killers threatening human health. More and more studies have confirmed that SUMO-specific protease 1 (SENP1) is over-expressed in various cancer tissues. Therefo... This review reports the latest advances in literature and patents on SENP1 inhibitor development over the past 10 years. With SENP1 as the keyword, articles and patents from PubMed, Google scholar and... The available complex crystal structures of SENP1-SUMO1, afforded structure-based drug design opportunities, which led to the development of various isoform-selective small molecule inhibitors belongi...

An updated patent review of IDO1 inhibitors for cancer (2018-2022).

Indoleamine 2,3-dioxygenase 1 (IDO1) is highly related to the immune evasion of a wide range of malignancies due to its role in the immune suppression caused by the depletion of tryptophan (Trp) and t... This review focuses on patent publications searched from Espacenet and Google Scholar, and related to IDO1 inhibitors with potential anti-cancer utilization during the period 2018-2022.... Despite the clinical trial failure of the first-in-class IDO1 inhibitor epacadostat in combination with pembrolizumab, numerous studies have been carried on to pursue more efficient IDO1-based immune-...

An updated patent review of anaplastic lymphoma kinase inhibitors (2018-2022).

Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, has emerged as a promising drug target for multiple cancers. Up to now, a total of seven ALK inhibitor... This paper provides a comprehensive review of the patent literature from 2018 to 2022 about structures, pharmacological data of small molecular ALK inhibitors, and their utilization as anticancer agen... To date, there are no ALK inhibitors that have been approved are completely free of resistance issues, which is a plight needing urgent solution. Development of new ALK inhibitors through structure mo...

Recent patent applications for coffee and coffee by-products as active ingredients in cosmetics.

Coffee is one of the most consumed beverages worldwide, and its production and consumption generate large amounts of by-products annually. Coffee by-products and coffee beans are rich in bioactive com... This review was carried out using Espacenet. The following inclusion criteria were established: patents that included the terms "coffee" and "skin" in the title, abstract and claims and belonged to th... Considering the 52 patents analysed, the bean was the main way to obtain extracts (39), followed by green beans (7), silverskin (3), peel and pulp (1), pulp (1) and beans and leaves (1). The formulati...

Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present).

The Hippo pathway represents a new opportunity for the treatment of cancer. Overexpression of Yes-associated protein (YAP) or transcriptional coactivator with PDZ-binding motif (TAZ) or TEAD has been ... This review is limited to published patent applications that have disclosed direct small-molecule inhibitors of the YAP/TAZ-TEAD interaction.... The YAP/TAZ-TEAD transcriptional complex is a promising target for the treatment of cancer. Approximately 30 international patents (used database: Sci-finder, query: TEAD; documents: patents; period: ...

Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022.

Cancer affects an increasing number of patients each year with an unacceptable death toll worldwide. A new therapeutic approach to combat tumors consists in targeting human carbonic anhydrase (hCA, EC... Small molecule hCA IX/XII and antibody drug conjugate inhibitors targeting the two enzymes and their applications in the management of cancer are discussed.... The available 3D crystal structures of hCA IX, XII as well as the off target isoforms hCA I and II, afforded structure-based drug design opportunities, which led to the development of various isoform-...